BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4546078)

  • 1. Proceedings: Pharmacological effects of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (BL 191).
    Sakurai M; Kitatani T; Nagato K; Sakaguchi T
    Jpn J Pharmacol; 1974; 24(0):s:68. PubMed ID: 4546078
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifyllin) on the cardiovascular system of the dog].
    Komarek J; Sakurai M
    Arzneimittelforschung; 1974 May; 24(5):781-3. PubMed ID: 4408132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacology of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine, a new peripheral vasodilator agent].
    Popendiker K; Boksay I; Bollmann V
    Arzneimittelforschung; 1971 Aug; 21(8):1160-71. PubMed ID: 4329076
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological activity of some 8-diethylaminomethyl N-methylated xanthines and hypoxanthines].
    Liberman SS; Al'tshuler RA; Gerchikov LN
    Farmakol Toksikol; 1970; 33(5):586-90. PubMed ID: 5493219
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the effects of some new derivatives of ethylenediamine on the cardiovascular system. Studies on general pharmacological properties.
    Filczewski M
    Acta Physiol Pol; 1974; 25(6):565-76. PubMed ID: 4456970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of No-Spa and papaverine on indices of cerebral circulation].
    Lanskiĭ VP
    Farmakol Toksikol; 1973; 36(1):23-6. PubMed ID: 4685149
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of a xanthine derivative, 1-(5' oxohexyl)-3-methyl-7-propylxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits.
    Hudlicka O; Komarek J; Wright AJ
    Br J Pharmacol; 1981 Apr; 72(4):723-30. PubMed ID: 7284688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of arpenal on cerebral circulation].
    Mirzoian SA; Gabrielian ES
    Farmakol Toksikol; 1969; 32(1):35-8. PubMed ID: 4388897
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoactive peptides.
    Sander GE; Huggins CG
    Annu Rev Pharmacol; 1972; 12():227-64. PubMed ID: 4339018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine on alpha-adrenergic effects].
    Boksay I; Bollmann V; Popendiker K
    Arzneimittelforschung; 1971 Aug; 21(8):1174-7. PubMed ID: 5110013
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of synthetic physalaemin.
    Nakano J; Darrow BA; McCurdy JR
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):429-34. PubMed ID: 5684254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
    Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Review of the cardiovascular pharmacology of perhexiline.
    Hudak WJ; Lewis RE; Lucas RW; Kuhn WL
    Postgrad Med J; 1973 Apr; 49():Suppl 3:16-25. PubMed ID: 4202743
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of antifibrinolytic drugs.
    Marmo E; Di Nola R; Rossi F
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):137-50. PubMed ID: 4542597
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of anisodamine on cardiovascular activities in endotoxin-shocked dogs.
    Yao T; Xiao YF; Sun XY; Tong HH; Yuan M; Xu ZY; Dai ZY
    Chin Med J (Engl); 1984 Dec; 97(12):871-6. PubMed ID: 6443282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of a new anti-angina preparation, nonachlazin].
    Kaverdina NV; Markova GA
    Farmakol Toksikol; 1975; 38(2):173-7. PubMed ID: 1227883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.